Persistent Asset Partners LTD Reviva Pharmaceuticals Holdings, Inc. Transaction History
Persistent Asset Partners LTD
- $145 Billion
- Q3 2025
A detailed history of Persistent Asset Partners LTD transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Persistent Asset Partners LTD holds 593,902 shares of RVPH stock, worth $296,951. This represents 0.15% of its overall portfolio holdings.
Number of Shares
593,902
Previous 641,174
7.37%
Holding current value
$296,951
Previous $244 Million
10.41%
% of portfolio
0.15%
Previous 0.18%
Shares
4 transactions
Others Institutions Holding RVPH
# of Institutions
50Shares Held
9.74MCall Options Held
585KPut Options Held
31.6K-
Diadema Partners LP Morristown, NJ2.51MShares$1.25 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.92MShares$961,6140.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.71MShares$855,6100.0% of portfolio
-
Geode Capital Management, LLC Boston, MA559KShares$279,6210.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA524KShares$262,0250.0% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $10.2M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...